Cyclometallated Iridium(III) Complexes: Ligand-Driven Selectivity for Chemotherapy and Photodynamic Therapy

Abstract

This study explores two cyclometallated Ir(III) complex families with distinct therapeutic profiles. Benzothiophene derivatives (1, 2) exhibit potent antiproliferative character in the dark, favoring chemotherapy, while benzothiazole analogs (3 and 4) show high photocytotoxicity, ideal for photodynamic therapy. Photophysical studies and subcellular localization analyses highlight ligand-driven selectivity and the role of organelle targeting in therapeutic outcomes.

Supplementary files

Article information

Article type
Communication
Submitted
18 Aug 2025
Accepted
30 Oct 2025
First published
05 Nov 2025
This article is Open Access
Creative Commons BY-NC license

Chem. Commun., 2025, Accepted Manuscript

Cyclometallated Iridium(III) Complexes: Ligand-Driven Selectivity for Chemotherapy and Photodynamic Therapy

V. Fernández-Moreira, E. Morales-Pioz, M. Redrado, A. Benedí Visiedo, A. de Aquino, P. García-Orduña, M. Royo-Cañas, J. Godino, I. Marzo, L. Rodriguez and M. C. Gimeno, Chem. Commun., 2025, Accepted Manuscript , DOI: 10.1039/D5CC04768D

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements